SS Innovations International (NASDAQ:SSII) Director Purchases $1,999,999.47 in Stock

SS Innovations International, Inc. (NASDAQ:SSII) Director Frederic Moll purchased 501,253 shares of SS Innovations International stock in a transaction dated Friday, March 6th. The shares were purchased at an average cost of $3.99 per share, for a total transaction of $1,999,999.47. Following the transaction, the director owned 10,775,485 shares in the company, valued at approximately $42,994,185.15. This trade represents a 4.88% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

SS Innovations International Trading Down 5.6%

SS Innovations International stock traded down $0.26 during mid-day trading on Tuesday, hitting $4.42. The company’s stock had a trading volume of 28,401 shares, compared to its average volume of 97,274. SS Innovations International, Inc. has a 1 year low of $3.02 and a 1 year high of $22.42. The firm has a market capitalization of $859.07 million and a PE ratio of -88.40. The stock’s fifty day moving average is $4.82 and its two-hundred day moving average is $6.05.

SS Innovations International (NASDAQ:SSII) last announced its quarterly earnings results on Tuesday, January 13th. The company reported $0.04 EPS for the quarter. The business had revenue of $14.53 million for the quarter. SS Innovations International had a negative return on equity of 34.13% and a negative net margin of 32.10%.

Institutional Investors Weigh In On SS Innovations International

Hedge funds have recently added to or reduced their stakes in the business. PNC Financial Services Group Inc. acquired a new position in shares of SS Innovations International during the 3rd quarter worth about $56,000. Jane Street Group LLC purchased a new stake in SS Innovations International during the fourth quarter worth approximately $63,000. IFC & Insurance Marketing Inc. purchased a new position in SS Innovations International in the fourth quarter valued at approximately $64,000. Goldman Sachs Group Inc. purchased a new stake in shares of SS Innovations International during the 4th quarter worth approximately $68,000. Finally, Envestnet Asset Management Inc. purchased a new stake in shares of SS Innovations International during the 3rd quarter worth approximately $71,000.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of SS Innovations International in a research report on Thursday, January 22nd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, SS Innovations International presently has a consensus rating of “Sell”.

About SS Innovations International

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.